These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8473043)

  • 1. Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region.
    Stewart M; Cameron E; Campbell M; McFarlane R; Toth S; Lang K; Onions D; Neil JC
    Int J Cancer; 1993 Apr; 53(6):1023-30. PubMed ID: 8473043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging.
    Blyth K; Terry A; Mackay N; Vaillant F; Bell M; Cameron ER; Neil JC; Stewart M
    Oncogene; 2001 Jan; 20(3):295-302. PubMed ID: 11313958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss.
    Blyth K; Terry A; O'Hara M; Baxter EW; Campbell M; Stewart M; Donehower LA; Onions DE; Neil JC; Cameron ER
    Oncogene; 1995 May; 10(9):1717-23. PubMed ID: 7753548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. til-1: a novel proviral insertion locus for Moloney murine leukaemia virus in lymphomas of CD2-myc transgenic mice.
    Stewart M; Terry A; O'Hara M; Cameron E; Onions D; Neil JC
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():443-6. PubMed ID: 8601779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
    Baxter EW; Blyth K; Cameron ER; Neil JC
    J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The common retroviral insertion locus Dsi1 maps 30 kilobases upstream of the P1 promoter of the murine Runx3/Cbfa3/Aml2 gene.
    Stewart M; MacKay N; Cameron ER; Neil JC
    J Virol; 2002 May; 76(9):4364-9. PubMed ID: 11932403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene.
    Schmidt T; Zörnig M; Beneke R; Möröy T
    Nucleic Acids Res; 1996 Jul; 24(13):2528-34. PubMed ID: 8692692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation of Myb and Myc proteins in T cell lymphomagenesis.
    Davies J; Badiani P; Weston K
    Oncogene; 1999 Jun; 18(24):3643-7. PubMed ID: 10380886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement.
    Tsatsanis C; Fulton R; Nishigaki K; Tsujimoto H; Levy L; Terry A; Spandidos D; Onions D; Neil JC
    J Virol; 1994 Dec; 68(12):8296-303. PubMed ID: 7966623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.
    Schmidt T; Karsunky H; Gau E; Zevnik B; Elsässer HP; Möröy T
    Oncogene; 1998 Nov; 17(20):2661-7. PubMed ID: 9840930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice.
    Cameron ER; Campbell M; Blyth K; Argyle SA; Keanie L; Neil JC; Onions DE
    Br J Cancer; 1996 Jan; 73(1):13-7. PubMed ID: 8554976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc.
    Haupt Y; Harris AW; Adams JM
    Oncogene; 1992 May; 7(5):981-6. PubMed ID: 1570158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in E mu L-MYC transgenic mice but not in animals infected with MoMuLV.
    Zörnig M; Grzeschiczek A; Kowalski MB; Hartmann KU; Möröy T
    Oncogene; 1995 Jun; 10(12):2397-401. PubMed ID: 7784089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moloney virus induction of T-cell lymphomas in a plasmacytomagenic strain of E mu-v-abl transgenic mice.
    Haupt Y; Harris AW; Adams JM
    Int J Cancer; 1993 Oct; 55(4):623-9. PubMed ID: 8406991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The programmed cell death of an immature thymocyte cell line transgenic for an alpha beta TCR and the c-myc proto-oncogene.
    Murdjeva M; Tanaka Y; Norton T; Kioussis D
    Dev Immunol; 1996; 4(4):279-88. PubMed ID: 8924763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
    Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
    Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development?
    Baxter EW; Blyth K; Donehower LA; Cameron ER; Onions DE; Neil JC
    J Virol; 1996 Apr; 70(4):2095-100. PubMed ID: 8642629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of lymphoid tumors induced by a recombinant murine retrovirus carrying the avian v-myc oncogene. Identification of novel (B-lymphoid) tumors in the thymus.
    Brightman BK; Chandy KG; Spencer RH; Gupta S; Pattengale PK; Fan H
    J Immunol; 1988 Oct; 141(8):2844-54. PubMed ID: 2902139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.
    Karsunky H; Geisen C; Schmidt T; Haas K; Zevnik B; Gau E; Möröy T
    Oncogene; 1999 Dec; 18(54):7816-24. PubMed ID: 10618723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc.
    Vaillant F; Blyth K; Terry A; Bell M; Cameron ER; Neil J; Stewart M
    Oncogene; 1999 Nov; 18(50):7124-34. PubMed ID: 10597314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.